ELV

Elevance Health, Inc.
—

Company Information

Company Name
Elevance Health, Inc.
CIK
CIK0001156039
Category
Large accelerated filer
Ticker: Exchange
ELV: NYSE
Fiscal Year End
December 31
Owner Organization
02 Finance
SIC
6324
SIC Description
Hospital & Medical Service Plans
Ticker
ELV

SEC filing data through

Insider Sentiment

Last purchase
2026-07-17
Last sale
2026-06-12
Shares purchased (TTM)
16,425
Shares sold (TTM)
5,273
Buy ratio (TTM)75.7%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
189,146,521
Shares outstanding
217,000,000
Ownership
87.16%
+3.11% Y/Y

Earnings Market Reaction

Filing date
2026-07-15
Price on filing date
—
1-month reaction
0.99%
3-month reaction
…
Drift continued4/11 (36%)
Faded / reversed7/11 (64%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value10,2329,6579,4918,7138,5607,5008,2887,8666,4976,2266,52610,919
Available For Sale Securities Debt Securities Current25,71925,90525,88426,28325,29825,43725,20128,95428,90029,53029,61427,811
Equity Securities Fv Ni1,5631,5117401,2209347151,1921,113594511229165
Premiums Receivable At Carrying Value10,99111,52510,0739,53510,46510,3598,0117,2098,0408,9317,9027,883
Assets Current
Assets Current67,18467,03263,00163,77863,32461,12158,94262,84662,27460,94860,02961,185
Other Receivables6,8186,1676,3077,6927,2066,5766,0166,0555,8815,1205,4055,293
Other Assets Current6,2787,1695,3445,2135,4075,2884,7005,9496,4646,3885,7955,358
Assets Held For Sale Not Part Of Disposal Group Current--0000490565601-0-
Long Term Investments
Available For Sale Securities Debt Securities Noncurrent1,2591,1141,1211,1111,0871,0601,035893849880876816
Other Long Term Investments11,13011,00910,83910,64810,46610,1679,7499,3946,8106,7136,1076,118
Property Plant And Equipment Net4,6454,6574,6794,6574,6414,6174,6524,5054,4504,4514,3594,248
Goodwill28,33928,34028,34428,45128,36828,42028,27725,96725,96225,94725,31725,291
Intangible Assets Net Excluding Goodwill10,98311,09311,20011,32711,49011,94012,09410,32510,44710,71010,27310,491
Other Assets Noncurrent2,8982,5822,3102,7772,5622,3922,1402,6032,1962,2451,9672,329
Assets126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478
Liabilities
Liability For Claims And Claims Adjustment Expense18,46318,42517,08417,14817,15516,81215,74615,34615,20416,45916,11116,176
Other Policyholder Funds3,4633,8573,6322,4473,5403,7964,2044,4024,9395,2985,6005,681
Unearned Premiums1,6401,7591,4931,8311,5611,6401,5081,7931,4811,4741,4024,332
Accounts Payable And Accrued Liabilities Current6,6326,2097,3226,0857,2787,1316,9276,2555,7605,6586,9105,983
Short Term Borrowings07241501803602503653602251,5752250
Long Term Debt Current3753501,0997491,6481,6431,6492,1002,9002,9001,649799
Other Liabilities Current13,68113,98510,25512,43812,29211,42610,02911,61411,13910,9709,89410,366
Liabilities Of Disposal Group Including Discontinued Operation Current--0000153163165-0-
Liabilities Current44,25445,30941,03540,87843,83442,69840,58142,03341,81344,33441,79143,337
Long Term Debt Noncurrent30,66930,76830,79731,17328,17828,11029,21824,68824,56121,97623,24624,045
Liability For Future Policy Benefits--145164163174190248295765778807
Deferred Income Tax Liabilities Net2,2061,7862,1102,3152,0082,1212,1482,0922,0372,2011,9701,779
Other Liabilities Noncurrent4,2873,9223,3814,1373,9043,9943,3263,5931,9851,9081,7381,971
Liabilities81,41681,78577,46878,66778,08777,09775,46372,65470,69171,18469,52371,939
Preferred Stock Value000000000000
Common Stock Value222222222222
Stockholders Equity
Additional Paid In Capital8,9178,8458,9388,9088,9318,8668,9119,1059,0018,8838,8688,830
Stockholders Equity45,02243,90243,88243,95343,72242,62041,42643,87942,19140,60839,30638,423
Retained Earnings Accumulated Deficit36,67535,79635,39335,58635,54934,54633,54935,15734,57533,08831,74932,103
Accumulated Other Comprehensive Income Loss Net Of Tax-711-741-451-543-760-911-1,147-489-1,387-1,365-1,313-2,512
Minority Interest13914014412912911711110410610299116
Liabilities And Stockholders Equity126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478
Debt Securities Available For Sale Amortized Cost Current25,96226,17725,77326,20025,49125,81325,87928,73929,83430,42730,44630,139
Debt Securities Available For Sale Allowance For Credit Loss Current55552113157624443
Debt Securities Available For Sale Amortized Cost Noncurrent1,2631,1211,1161,1101,0991,0701,049883867902890874
Debt Securities Available For Sale Allowance For Credit Loss Noncurrent000000000000
Preferred Stock Shares Authorized100100100100100100100100100100100100
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized900900900900900900900900900900900900
Common Stock Shares Issued217217221222225226227232232233233235
Shares Outstanding217217221222225226227232232233233235

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Elevance Health, Inc. (ELV) — SEC Financial Statements & Analysis

Elevance Health, Inc. (ELV) is a hospital & medical service plans company, incorporated in IN. Elevance Health, Inc. trades on NYSE as: ELV. Elevance Health, Inc. (ELV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-15. Based on that filing, Elevance Health, Inc. carries a market cap of $83.92B, a P/E ratio of 16.96x, a P/B ratio of 1.86x, a P/S ratio of 0.42x, an enterprise value of $104.73B, and an EV/EBITDA multiple of 13.34x. On profitability, it posts a gross margin of 89.12%, an operating margin of 2.92%, a net margin of 2.46%, a Return on Equity (ROE) of 11.14%, a Return on Assets (ROA) of 3.99%, and a Return on Invested Capital (ROIC) of 8.82%. Per share, it reports EPS of $22.81, diluted EPS of $22.71, free cash flow per share of $28.98, and a dividend per share of $6.94. Over the trailing year, it posted revenue growth of -9.47% year-over-year, net income growth of -7.51% year-over-year, and EPS growth of -4.02% year-over-year. On the balance sheet, it maintains a current ratio of 1.52x, a quick ratio of 1.52x, working capital of $22.93B, a debt-to-equity ratio of 1.81x, a debt ratio of 0.64, an interest coverage ratio of 5.08x, free cash flow of $6.29B (TTM), and net debt of $20.81B. Figures sourced from SEC EDGAR.

Market Cap
$83.92B
P/E TTM
16.96x
EPS TTM
$22.81
P/B TTM
1.86x
ROE TTM
11.14%
ROA TTM
3.99%
Debt To Equity
1.81x
Free Cash Flow TTM
$6.29B
Net Revenue TTM Growth 1Y
-9.47%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Elevance Health, Inc. in?

Elevance Health, Inc. (ELV) operates in the Hospital & Medical Service Plans industry.

What exchange does ELV trade on?

Elevance Health, Inc. (ELV) trades on the NYSE.

Where is Elevance Health, Inc. incorporated?

Elevance Health, Inc. is incorporated in IN.

When was Elevance Health, Inc. (ELV)'s most recent SEC filing?

Elevance Health, Inc. (ELV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-15.

What is ELV's market cap?

Elevance Health, Inc. (ELV) has a market capitalization of $83.92B as of 2026-06-30.

What is ELV's P/E ratio?

Elevance Health, Inc. (ELV)'s trailing twelve month P/E ratio is 16.96x as of 2026-06-30.

What is ELV's EPS (earnings per share)?

Elevance Health, Inc. (ELV)'s trailing twelve month EPS is $22.81 as of 2026-06-30.

What is ELV's ROE (return on equity)?

Elevance Health, Inc. (ELV)'s trailing twelve month Return on Equity (ROE) is 11.14% as of 2026-06-30.

What is ELV's ROA (return on assets)?

Elevance Health, Inc. (ELV)'s trailing twelve month Return on Assets (ROA) is 3.99% as of 2026-06-30.

What is ELV's ROIC (return on invested capital)?

Elevance Health, Inc. (ELV)'s trailing twelve month Return on Invested Capital (ROIC) is 8.82% as of 2026-06-30.

What is ELV's EV/EBITDA?

Elevance Health, Inc. (ELV)'s trailing twelve month EV/EBITDA is 13.34x as of 2026-06-30.

Wall Street's data.
Main Street's price.